Literature DB >> 11683576

The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy.

A M Dyrhol-Riise1, G Stent, B I Røsok, P Voltersvik, J Olofsson, B Asjö.   

Abstract

Apoptosis has been proposed as a mechanism responsible for T cell depletion in HIV-1 infection. In the present study we have phenotyped apoptotic T cells in tonsillar lymphoid tissue from 11 HIV-1-infected patients by flow cytometry light-scatter characteristics during 48 weeks of highly active antiretroviral therapy (HAART). We found that the decline in tonsillar viral load was associated with a decrease in the proportion of apoptotic CD4+ and CD8+ T cells. CD4 cell apoptosis was predominantly seen within the memory CD28+ Fas+ FasL+ population. The increased level of apoptotic CD8+ T cells was found among activated Fas+ memory cells irrespective of CD28 and FasL expression. These T cell subsets were expanded in untreated infection, but normalized with therapy. We conclude that HIV-1 triggers FasL-mediated apoptosis of uninfected CD4+ T cells, whereas CD8+ T cell apoptosis is driven by chronic immune activation. Virus suppression reverses both of these mechanisms, contributing to immune reconstitution during HAART. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11683576     DOI: 10.1006/clim.2001.5101

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Differential expression of IFN-alpha and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients.

Authors:  Jean-Philippe Herbeuval; Jakob Nilsson; Adriano Boasso; Andrew W Hardy; Michael J Kruhlak; Stephanie A Anderson; Matthew J Dolan; Michel Dy; Jan Andersson; Gene M Shearer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-21       Impact factor: 11.205

Review 2.  Studies of HIV-associated immune responses in lymphoid compartments.

Authors:  Susanna Grundström; Jan Andersson
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

3.  Peripheral blood mononuclear cells of HIV-infected patients contain CD8 T cells that form conjugates with and kill HIV-infected autologous CD4 T cells.

Authors:  Ehud Chorin; Orit Gal-Garber; Yael Yagel; Dan Turner; Boaz Avidor; Gideon Berke; David Hassin
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

4.  HAART reduces death ligand but not death receptors in lymphoid tissue of HIV-infected patients and simian immunodeficiency virus-infected macaques.

Authors:  Jean-Philippe Herbeuval; Jakob Nilsson; Adriano Boasso; Andrew W Hardy; Monica Vaccari; Valentina Cecchinato; Valerio Valeri; Genoveffa Franchini; Jan Andersson; Gene M Shearer
Journal:  AIDS       Date:  2009-01-02       Impact factor: 4.177

5.  c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells.

Authors:  Xue Wang; Jiangqin Zhao; Shixing Tang; Sherwin Lee; Robert I Glazer; Indira Hewlett
Journal:  Mol Cell Biochem       Date:  2009-04-11       Impact factor: 3.396

Review 6.  Making sense of how HIV kills infected CD4 T cells: implications for HIV cure.

Authors:  Nathan W Cummins; Andrew D Badley
Journal:  Mol Cell Ther       Date:  2014-07-03

Review 7.  Type I Interferon at the Interface of Antiviral Immunity and Immune Regulation: The Curious Case of HIV-1.

Authors:  Adriano Boasso
Journal:  Scientifica (Cairo)       Date:  2013-12-22

8.  Selective cell death of latently HIV-infected CD4+ T cells mediated by autosis inducing nanopeptides.

Authors:  Gang Zhang; Brian T Luk; Xiaoli Wei; Grant R Campbell; Ronnie H Fang; Liangfang Zhang; Stephen A Spector
Journal:  Cell Death Dis       Date:  2019-05-29       Impact factor: 8.469

9.  Cardiac morbidity in HIV infection is associated with checkpoint inhibitor LAG-3 on CD4 T cells.

Authors:  Suresh Pallikkuth; Rajendra Pahwa; Bagavathi Kausalya; Shanmugam Saravanan; Li Pan; R Vignesh; Syed Iqbal; Sunil S Solomon; Kailapuri G Murugavel; Selvamuthu Poongulali; Nagalingeswaran Kumarasamy; Savita Pahwa
Journal:  PLoS One       Date:  2018-10-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.